课题基金 / 基金详情

SELECTINS ROLE IN VASCULAR INJURY IN GENE-TARGETED

SELECTINS ROLE IN VASCULAR INJURY IN GENE-TARGETED
选择素在基因靶向血管损伤中的作用
批准号:
6702627
负责人:
IAN J SAREMBOCK
金额:
$33.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-02-01 至 2005-01-31

项目摘要

项目成果

IAN J SAREMBOCK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Restenosis after percutaneous interventions remain a major challenge, occurring in 20-40 percent after balloon angioplasty or stents. Neointima formation is an important mechanism and represents a complex healing process that includes adhesive interactions between inflammatory cells and the vessel wall. The selectin adhesion molecules participate in the early steps of leukocyte recruitment but their exact role after vascular injury is incompletely understood. Accordingly, the primary goal of this proposal is to understand the role of E- and P-selectin and their interactions on neutrophil and macrophage/foam cell accumulation and neointimal growth following arterial injury using gene-targeted mice deficient in expression of apoE plus P-selectin and/or E-selectin and monoclonal antibodies directed against E- and/or P-selectin. SpecificAim1 will test the hypothesis that elimination of P-selectin and/or E-selectin by gene-targeting limits leukocyte entry and accumulation and neointima formation following carotid denudation injury in apoE deficient mice. Histomorphometry and detailed immunohistochemical analysis will be utilized together with serial MRI imaging. Although P-selectin has recently been shown to occupy a preeminent role in regulating leukocyte behavior in a mouse model of inflammation, both discrete functional differences and similar/overlapping functions are described for E- and Pselectin. Accordingly, Specific Aim 2 will test the hypothesis that transient inhibition of E-selectin, P-selectin or both using blocking monoclonal antibodies each or together limit leukocyte entry and accumulation and neointima formation following carotid denudation injury in gene-targeted mice deficient in expression of apoE. To address the specific mechanism(s) by which P-selectin is anticipated to exert its protective effect on vascular repair after wire denudation injury, bone marrow transplantation will be performed in aim 3. Specific Aim 3 will test the hypothesis that platelet P-selectin is responsible for the protective effect of P-selectin deletion/blockade on leukocyte accumulation and neointima formation following carotid denudation injury in gene-targeted mice deficient in expression of apoE. Taken together, these studies will provide new insights into the role(s) of the selectins in inflammatory cell trafficking and neointimal growth after vascular injury in atherosclerosis-prone apoE-deficient mice. In addition, these studies will open new avenues to potential therapeutic strategies to limit neointimal growth after vascular injury.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1083/jcb.200410073
发表时间: 2005-04-11
期刊: JOURNAL OF CELL BIOLOGY
影响因子: 7.8
作者: [Orr, A Wayne, Sanders, John M, Bevard, Melissa, Coleman, Elizabeth, Sarembock, Ian J, Schwartz, Martin Alexander]
通讯作者: Schwartz, Martin Alexander
DOI: 10.1083/jcb.200609008
发表时间: 2007-02-26
期刊: JOURNAL OF CELL BIOLOGY
影响因子: 7.8
作者: [Orr, A Wayne, Stockton, Rebecca, Simmers, Michael B, Sanders, John M, Sarembock, Ian J, Blackman, Brett R, Schwartz, Martin Alexander]
通讯作者: Schwartz, Martin Alexander
SELECTINS ROLE IN VASCULAR INJURY IN GENE-TARGETED
  • 批准号:
    6629152
  • 项目类别:
  • 资助金额:
    $32.8万
  • 财政年份:
    2001
  • 负责人:
    IAN J SAREMBOCK
  • 依托单位:
SELECTINS ROLE IN VASCULAR INJURY IN GENE-TARGETED MICE
  • 批准号:
    6499173
  • 项目类别:
  • 资助金额:
    $31.82万
  • 财政年份:
    2001
  • 负责人:
    IAN J SAREMBOCK
  • 依托单位:
SELECTINS ROLE IN VASCULAR INJURY IN GENE-TARGETED MICE
  • 批准号:
    6232536
  • 项目类别:
  • 资助金额:
    $32.74万
  • 财政年份:
    2001
  • 负责人:
    IAN J SAREMBOCK
  • 依托单位:
NOVEL ADENOSINE A2A AGONISTS IN VASCULAR PROTECTION
  • 批准号:
    6206916
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2000
  • 负责人:
    IAN J SAREMBOCK
  • 依托单位:
海外基金